- Home
- LSBK vs ORMP Comparison
LSBK vs ORMP Comparison
Compare LSBK & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LSBK | ORMP |
|---|---|---|
| Founded | 1891 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 135.5M | 197.6M |
| IPO Year | 2025 | 2010 |
Fundamental Metrics
Financial Performance| Metric | LSBK | ORMP |
|---|---|---|
| Price | $17.82 | $4.73 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 22.8K | ★ 160.5K |
| Earning Date | 04-22-2026 | 05-14-2026 |
| Dividend Yield | 2.27% | ★ 6.51% |
| EPS Growth | 49.23 | ★ 412.50 |
| EPS | 0.56 | ★ 2.76 |
| Revenue | N/A | ★ $2,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $31.50 | ★ $1.74 |
| Revenue Growth | N/A | ★ 49.25 |
| 52 Week Low | $12.50 | $2.09 |
| 52 Week High | $19.09 | $5.47 |
Technical Indicators
Market Signals| Indicator | LSBK | ORMP |
|---|---|---|
| Relative Strength Index (RSI) | 50.92 | 51.06 |
| Support Level | $16.84 | $3.91 |
| Resistance Level | $19.09 | $5.01 |
| Average True Range (ATR) | 0.66 | 0.15 |
| MACD | -0.06 | -0.02 |
| Stochastic Oscillator | 37.31 | 43.62 |
Price Performance
Historical ComparisonAbout LSBK Lake Shore Bancorp Inc.
Lake Shore Bancorp Inc operates as a savings and loan holding company. The bank's business consists of attracting retail deposits from the general public in the areas surrounding its branch offices and investing those deposits, together with funds generated from operations, in commercial real estate loans, one-to-four family residential mortgage loans, home equity lines of credit, and, to a lesser extent, commercial business loans, consumer loans, and investment securities. Its revenues are principally derived from interest earned on loans and investment securities.
About ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. The company has developed an oral dosage form intended to withstand the harsh environment of the gastrointestinal tract and effectively deliver active insulin or other proteins. Its product pipeline includes ORMD-0801 for Diabetes, ORMD-0801 for NASH, and ORMD 0901.